QA: Nanoviricides INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2021_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 13,985,657
1 IntangibleAssetsNetIncludingGoodwill 358,388
2 PropertyPlantAndEquipmentNet 9,544,431
3 remainder_Assets 25,863
4 LiabilitiesCurrent 2,156,377
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,247,027
9 ResearchAndDevelopmentExpense 4,790,880
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -3,249,489
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,914,339
1 Liabilities 2,156,377
2 Expenses 8,037,907
3 Revenues 0
4 StockholdersEquity 21,757,962
5 NetIncome -11,287,396
6 ComprehensiveNetIncome -11,287,396
7 BaseVar 18,679,056
8 EconomicCapitalRatiobeforeLimitedLiability 2.77
9 EconomicCapitalRatio 3.54

Edgar->Model Mapping

Feature Distribution

Change over Time